Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine.
about
Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for interventionClinical trials of dendritic cell-based cancer vaccines in hematologic malignanciesTrial Watch-Immunostimulation with cytokines in cancer therapyPhase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury.EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab.WEE1 inhibition alleviates resistance to immune attack of tumor cells undergoing epithelial-mesenchymal transition.New insights into the role of EMT in tumor immune escape.Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis.Impact of Brachyury on epithelial-mesenchymal transitions and chemosensitivity in non-small cell lung cancer.Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody.Trial watch: Naked and vectored DNA-based anticancer vaccinesThe generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic.MUC1 upregulation promotes immune resistance in tumor cells undergoing brachyury-mediated epithelial-mesenchymal transition.Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies.An immunotherapeutic intervention against tumor progression: Targeting a driver of the epithelial-to-mesenchymal transition.Immunogenicity of targeted lentivectors.Therapeutic Targeting of Epithelial Plasticity Programs: Focus on the Epithelial-Mesenchymal Transition.Pharmacological and immunological targeting of tumor mesenchymalization.Development of Cancer Vaccines Targeting Brachyury, a Transcription Factor Associated with Tumor Epithelial-Mesenchymal Transition.Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer.Construction and Immunogenicity Testing of Whole Recombinant Yeast-Based T-Cell Vaccines.Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung CancerThe embryonic Brachyury transcription factor is a novel biomarker of GIST aggressiveness and poor survival.Brachyury-YAP Regulatory Axis Drives Stemness and Growth in Cancer.Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review.
P2860
Q21129293-3CB97CF5-DB8C-4843-B96B-011F83010669Q26864603-CD56C7F8-1C24-4796-B33E-20CB03F0A3E5Q28078725-75518D90-3CD6-4927-9E6B-9D5284289F73Q33275671-9CE67034-4D2B-4ACD-A43B-ED3B4F161CFFQ33276007-48CECBEF-6FAB-49F6-9EB1-903F72586B56Q33276035-FD39A70A-0268-4E57-BF4B-C841DBD3EAC5Q33570786-2382A081-5C1D-4388-8AE1-45A94BC629DBQ33869781-A82500F6-734B-40E4-9FF3-5B4F29CAB493Q34642305-47AEE903-88B0-4C51-AD6E-995879CAE362Q35628355-11E10804-C712-44E0-9C47-E799E4FB5E7AQ35741566-1C47D38B-0943-4F76-80F5-069AF606C86EQ35798986-D1CA17E6-A601-4C89-8A81-D9B437FE11C8Q36544576-044D64B5-3563-4884-91A0-6A8B4EDA407FQ36821095-8D5D1076-DEB9-4920-A302-25BEB8C8BF83Q37330932-2346719E-914F-4A6E-9118-DEB903A4936DQ37593566-AA69E61A-A4FD-465D-88A2-508EE420204FQ37718447-A3172DC8-6B99-4117-98E5-D4576285385EQ38953751-6004D7FD-B9DD-4BC9-950F-C3B93E9A61F0Q39029043-D908B561-4B8C-4F3B-852D-93937C77409AQ39142273-910671A5-DD5A-4867-8B1A-5FDBF9CFBE73Q39435498-C419E19E-AEAA-4261-824D-ED7AA2BF35DAQ40801573-A9607008-D32C-4A1B-9A0A-F3FF14925444Q41552614-25DB001E-4AB9-405D-9E53-0BF69F0AEFF9Q41725776-5703BE0E-B449-435D-9D4B-4268796FB9E1Q42260320-BA1EA867-8787-4002-9012-6CDD4D1EAF4FQ48146199-BBC9EBD3-16ED-4DC5-96AD-3BA1CD483A7B
P2860
Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunological targeting of tum ...... inant brachyury-yeast vaccine.
@en
Immunological targeting of tum ...... inant brachyury-yeast vaccine.
@nl
type
label
Immunological targeting of tum ...... inant brachyury-yeast vaccine.
@en
Immunological targeting of tum ...... inant brachyury-yeast vaccine.
@nl
prefLabel
Immunological targeting of tum ...... inant brachyury-yeast vaccine.
@en
Immunological targeting of tum ...... inant brachyury-yeast vaccine.
@nl
P2093
P2860
P356
P1433
P1476
Immunological targeting of tum ...... inant brachyury-yeast vaccine.
@en
P2093
Alessandra Jales
Andressa Ardiani
Bruce Huang
Claudia Palena
David Apelian
Duane H Hamilton
James W Hodge
Jeffrey Schlom
Mary T Litzinger
Romaine I Fernando
P2860
P304
P356
10.18632/ONCOTARGET.1295
P407
P577
2013-10-01T00:00:00Z